Complication Rates of Peripherally Inserted Central Catheters in Oncologic Versus Non-Oncologic Patients

IF 2.3 4区 医学 Q1 NURSING
{"title":"Complication Rates of Peripherally Inserted Central Catheters in Oncologic Versus Non-Oncologic Patients","authors":"","doi":"10.1016/j.soncn.2024.151681","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p><span><span><span>Peripherally inserted central catheters are commonly used in cancer patients and provide </span>vascular access for the administration of chemotherapy, antibiotics, or </span>parenteral nutrition. Besides many advantages, they represent a source of possible complications such as </span>catheter related blood stream infection<span>, catheter occlusion, or thrombosis. In this study, the catheter-related complication rate between oncologic and non-oncologic patients was compared.</span></p></div><div><h3>Methods</h3><p>This retrospective cohort-study included 411 patients who underwent their first catheter placement at the Vienna General Hospital—Medical University of Vienna from January 2013 to June 2018. Patient demographics and catheter-related parameters were collected and statistically analyzed using a competing risk model.</p></div><div><h3>Results</h3><p>Mean catheter dwell time was 27.75 days. The overall complication rate was 7.54% (2.72 per 1000 catheter days). Underlying malignant disease (hazard ratio: 0.351, 95% confidence interval [CI]: 0.133-0.929, <em>P</em> = .035) and chemotherapy administration (hazard ratio: 2.837, 95% CI: 1.088-7.394, <em>P</em> = .033) were significantly associated with the occurrence of any kind of complication. Catheter related blood stream infection was observed among 11 (2.68%) patients and again significantly associated with chemotherapy administration (hazard ratio: 4.545, 95% CI: 1.178-17.539; <em>P</em> = .028). Thrombosis was found in 7 (1.70%) patients and occlusion in 13 (3.16%) cases.</p></div><div><h3>Conclusions and implications for nursing practice</h3><p>Choice of venous access is an interdisciplinary decision with emphasis on patient participation. In oncologic patients, our data suggests that the benefits of peripherally inserted central catheters regarding costs, invasiveness, and accessibility might be outweighed by the higher rate of complications associated with the device. This becomes even more important in a community care setting, where standardized handling procedures and patient education play a pivotal role in device safety.</p></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Oncology Nursing","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0749208124001426","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Peripherally inserted central catheters are commonly used in cancer patients and provide vascular access for the administration of chemotherapy, antibiotics, or parenteral nutrition. Besides many advantages, they represent a source of possible complications such as catheter related blood stream infection, catheter occlusion, or thrombosis. In this study, the catheter-related complication rate between oncologic and non-oncologic patients was compared.

Methods

This retrospective cohort-study included 411 patients who underwent their first catheter placement at the Vienna General Hospital—Medical University of Vienna from January 2013 to June 2018. Patient demographics and catheter-related parameters were collected and statistically analyzed using a competing risk model.

Results

Mean catheter dwell time was 27.75 days. The overall complication rate was 7.54% (2.72 per 1000 catheter days). Underlying malignant disease (hazard ratio: 0.351, 95% confidence interval [CI]: 0.133-0.929, P = .035) and chemotherapy administration (hazard ratio: 2.837, 95% CI: 1.088-7.394, P = .033) were significantly associated with the occurrence of any kind of complication. Catheter related blood stream infection was observed among 11 (2.68%) patients and again significantly associated with chemotherapy administration (hazard ratio: 4.545, 95% CI: 1.178-17.539; P = .028). Thrombosis was found in 7 (1.70%) patients and occlusion in 13 (3.16%) cases.

Conclusions and implications for nursing practice

Choice of venous access is an interdisciplinary decision with emphasis on patient participation. In oncologic patients, our data suggests that the benefits of peripherally inserted central catheters regarding costs, invasiveness, and accessibility might be outweighed by the higher rate of complications associated with the device. This becomes even more important in a community care setting, where standardized handling procedures and patient education play a pivotal role in device safety.

肿瘤患者与非肿瘤患者外周置入中心导管的并发症发生率。
目的:外周置入中心导管常用于癌症患者,为化疗、抗生素或肠外营养的给药提供血管通路。外周置入中心导管除了具有许多优点外,还可能引起一些并发症,如导管相关血流感染、导管闭塞或血栓形成。本研究比较了肿瘤患者和非肿瘤患者导管相关并发症的发生率:这项回顾性队列研究纳入了 2013 年 1 月至 2018 年 6 月期间在维也纳总医院-维也纳医科大学接受首次导管置入手术的 411 名患者。研究收集了患者的人口统计学特征和导管相关参数,并使用竞争风险模型进行了统计分析:导管平均停留时间为 27.75 天。总并发症发生率为 7.54%(每 1000 个导管天 2.72 例)。潜在恶性疾病(危险比:0.351,95% 置信区间[CI]:0.133-0.929,P = .035)和化疗用药(危险比:2.837,95% 置信区间[CI]:1.088-7.394,P = .033)与各种并发症的发生显著相关。11例(2.68%)患者出现导管相关血流感染,同样与化疗用药密切相关(危险比:4.545,95% CI:1.178-17.539;P = .028)。7例(1.70%)患者出现血栓形成,13例(3.16%)出现闭塞:结论和对护理实践的启示:静脉通路的选择是一个跨学科的决定,重点在于患者的参与。在肿瘤患者中,我们的数据表明,外周置入中心导管在成本、侵入性和可及性方面的优势可能会被其较高的并发症发生率所抵消。在社区护理环境中,这一点变得更加重要,因为在社区护理环境中,标准化处理程序和患者教育对设备安全起着至关重要的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Seminars in Oncology Nursing
Seminars in Oncology Nursing Nursing-Oncology (nursing)
CiteScore
3.40
自引率
0.00%
发文量
68
审稿时长
45 days
期刊介绍: Seminars in Oncology Nursing is a unique international journal published six times a year. Each issue offers a multi-faceted overview of a single cancer topic from a selection of expert review articles and disseminates oncology nursing research relevant to patient care, nursing education, management, and policy development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信